PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Phenotype | |type 2 diabetes |
| Sentences | 116 |
| PubMedID- 24860832 | However, it is still unclear whether the clustering of these risk factors cumulatively increases the carotid atherosclerosis burden in patients with type 2 diabetes. |
| PubMedID- 19806159 | High fat stores in ectopic compartments in men with newly diagnosed type 2 diabetes: an anthropometric determinant of carotid atherosclerosis and insulin resistance. |
| PubMedID- 20686328 | The correlation between cvr-r and carotid atherosclerosis in type 2 diabetes mellitus patients with diabetic neuropathy. |
| PubMedID- 20516379 | The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the diabetic atherosclerosis prevention by cilostazol (dapc) study: a randomized trial. |
| PubMedID- 23204248 | In contrast, observational and experimental data suggest that c-peptide may play a causal role in the pathophysiology of arteriosclerosis in patients with early type 2 diabetes. |
| PubMedID- 22763581 | In a cross-sectional study [70] examining a situation of frank cardiovascular damage, lower serum esrage levels and higher serum age levels were found associated with dyslipidemia and atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 23573090 | Assessment of carotid atherosclerosis in type 2 diabetes mellitus patients with microalbuminuria by high-frequency ultrasonography. |
| PubMedID- 26120789 | Mean platelet volume is closely associated with serum glucose level but not with arterial stiffness and carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 20185862 | In conclusion, can was associated independently with cac, which suggests that can is a risk factor of coronary atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 20593206 | The objective of this study is to investigate the correlation of urinary albumin excretion rate (uaer) with the incidence of coronary heart disease (chd), pathological characteristics and severity of coronary atherosclerosis in patients with type 2 diabetes mellitus (t2dm), and explore the efficacy of using the urinary albumin excretion rate (uaer) to predict the risk of chd in patients with t2dm. |
| PubMedID- 24396696 | Association between cardiac autonomic neuropathy, diabetic retinopathy and carotid atherosclerosis in patients with type 2 diabetes. |
| PubMedID- 20200310 | The suppression of at least two (mcp-1 and rantes) of the three (mcp-1, rantes, and fractalkine) most important chemokines involved in the pathogenesis of atherosclerosis in patients with type 2 diabetes is relevant because two-thirds of mortality in this condition is attributable to atherosclerotic complications of coronary heart disease, cerebrovascular disease, and peripheral arterial disease. |
| PubMedID- 24739810 | Increased levels of adma were found in the development of carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm) [22], in subjects with early asymptomatic carotid atherosclerosis [23], and especially in patients with chronic kidney disease (ckds) and rheumatoid arthritis [24]. |
| PubMedID- 24023518 | The findings of the periscope study support theconclusion that treatment with the insulin-sensitizing tzd pioglitazone compared with glimepiridecan prevent the progression of atherosclerosis in patients with type 2 diabetes during 18 months oftreatment. |
| PubMedID- 24551481 | Association between framingham risk score and subclinical atherosclerosis among elderly with both type 2 diabetes mellitus and healthy subjects. |
| PubMedID- 21294693 | Glyoxalase i and aldose reductase gene polymorphisms and susceptibility to carotid atherosclerosis in type 2 diabetes. |